Psychometric properties of screening questionnaires to detect depression in primary healthcare setting in rural Ethiopia.


Journal

BMC primary care
ISSN: 2731-4553
Titre abrégé: BMC Prim Care
Pays: England
ID NLM: 9918300889006676

Informations de publication

Date de publication:
02 06 2022
Historique:
received: 12 12 2021
accepted: 23 05 2022
entrez: 2 6 2022
pubmed: 3 6 2022
medline: 7 6 2022
Statut: epublish

Résumé

Much of the research about the validity of depression screening questionnaires is on criterion validity. Evidence is scarce on the concurrent, convergent and construct validity of these measures, particularly from low-income countries. This study aimed to evaluate the psychometric properties of depression screening questionnaires in primary healthcare (PHC) in rural Ethiopia. A facility-based cross-sectional study was conducted with 587 participants recruited from patients attending three PHC facilities and two 'Holy water sites' (places where religious treatment is being provided). The psychometric properties of five mental health screening questionnaires were evaluated: the nine item Patient Health Questionnaire (PHQ-9), the two item version of PHQ-9 (PHQ-2), a version of PHQ-9 with two added items of irritability and noise intolerance (PHQ-11), the Patient Health Questionnaire-15 (PHQ-15), and the World Health Organization-Five Well-being Index (WHO-5). Clinical diagnosis of depression was ascertained by psychiatrists. We analyzed data using exploratory factor analysis, Spearman's rank order correlation coefficient (Rho), the Mann Whitney test of the equality of medians, univariate logistic regression and Cronbach's alpha. PHQ-9, PHQ-11 and WHO-5 were found to be unidimensional, with items in each scale highly loading onto one factor (factor loadings ranging from 0.64 to 0.87). The items of each instrument were internally consistent, with Cronbach's alpha ranging from 0.72 (PHQ-2) to 0.89 (PHQ-11). Scores for all screening scales were moderately or highly correlated with each other (Rho = 0.58 to 0.98) and moderately correlated with anxiety and disability scores. Median scores of all screening scales were significantly higher in those diagnosed with depression. The association of items measuring emotional and cognitive symptoms with the diagnosis of depression was stronger than the association with items measuring somatic symptoms. Irritability and noise intolerance had higher association with depression diagnosis than PHQ-9 items. Emotional and cognitive symptoms are more useful than somatic symptoms to predict the diagnosis of depression in the PHC context in Ethiopia. Future research should focus on testing the unidimensionality of PHQ-9, PHQ-11 and WHO-5 using confirmatory factor analysis; establishing the criterion validity of PHQ-11 and WHO-5; and on assessing test-retest reliability of all the measures.

Sections du résumé

BACKGROUND
Much of the research about the validity of depression screening questionnaires is on criterion validity. Evidence is scarce on the concurrent, convergent and construct validity of these measures, particularly from low-income countries. This study aimed to evaluate the psychometric properties of depression screening questionnaires in primary healthcare (PHC) in rural Ethiopia.
METHODS
A facility-based cross-sectional study was conducted with 587 participants recruited from patients attending three PHC facilities and two 'Holy water sites' (places where religious treatment is being provided). The psychometric properties of five mental health screening questionnaires were evaluated: the nine item Patient Health Questionnaire (PHQ-9), the two item version of PHQ-9 (PHQ-2), a version of PHQ-9 with two added items of irritability and noise intolerance (PHQ-11), the Patient Health Questionnaire-15 (PHQ-15), and the World Health Organization-Five Well-being Index (WHO-5). Clinical diagnosis of depression was ascertained by psychiatrists. We analyzed data using exploratory factor analysis, Spearman's rank order correlation coefficient (Rho), the Mann Whitney test of the equality of medians, univariate logistic regression and Cronbach's alpha.
RESULTS
PHQ-9, PHQ-11 and WHO-5 were found to be unidimensional, with items in each scale highly loading onto one factor (factor loadings ranging from 0.64 to 0.87). The items of each instrument were internally consistent, with Cronbach's alpha ranging from 0.72 (PHQ-2) to 0.89 (PHQ-11). Scores for all screening scales were moderately or highly correlated with each other (Rho = 0.58 to 0.98) and moderately correlated with anxiety and disability scores. Median scores of all screening scales were significantly higher in those diagnosed with depression. The association of items measuring emotional and cognitive symptoms with the diagnosis of depression was stronger than the association with items measuring somatic symptoms. Irritability and noise intolerance had higher association with depression diagnosis than PHQ-9 items.
CONCLUSION
Emotional and cognitive symptoms are more useful than somatic symptoms to predict the diagnosis of depression in the PHC context in Ethiopia. Future research should focus on testing the unidimensionality of PHQ-9, PHQ-11 and WHO-5 using confirmatory factor analysis; establishing the criterion validity of PHQ-11 and WHO-5; and on assessing test-retest reliability of all the measures.

Identifiants

pubmed: 35655164
doi: 10.1186/s12875-022-01755-2
pii: 10.1186/s12875-022-01755-2
pmc: PMC9161478
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

138

Subventions

Organisme : Medical Research Council
ID : MR/M025470/1
Pays : United Kingdom

Informations de copyright

© 2022. The Author(s).

Références

Psychiatr Serv. 2009 Mar;60(3):322-8
pubmed: 19252044
Can J Psychiatry. 2013 Aug;58(8):442-8
pubmed: 23972105
Soc Psychiatry Psychiatr Epidemiol. 2006 Jun;41(6):444-51
pubmed: 16572275
J Affect Disord. 2020 Nov 1;276:220-233
pubmed: 32697702
BMJ. 2001 Feb 17;322(7283):406-9
pubmed: 11179161
Int J Behav Med. 2013 Jun;20(2):172-83
pubmed: 22618306
Psychosom Med. 2002 Mar-Apr;64(2):258-66
pubmed: 11914441
J Affect Disord. 2014 Mar;156:240-4
pubmed: 24412323
Compr Psychiatry. 2014 Apr;55(3):743-8
pubmed: 24342054
PLoS One. 2011 Jan 25;6(1):e16049
pubmed: 21283565
Glob Health Res Policy. 2018 Sep 10;3:26
pubmed: 30214943
Arch Intern Med. 2006 May 22;166(10):1092-7
pubmed: 16717171
Int J Methods Psychiatr Res. 2003;12(1):22-33
pubmed: 12830307
CMAJ. 2008 Apr 8;178(8):997-1003
pubmed: 18390942
Int J Ment Health Syst. 2019 Jul 17;13:50
pubmed: 31346349
Gen Hosp Psychiatry. 1992 Jul;14(4):237-47
pubmed: 1505745
Diabet Med. 2013 Feb;30(2):e63-9
pubmed: 23072401
BMC Fam Pract. 2017 Apr 21;18(1):56
pubmed: 28431526
BMJ. 2019 Apr 8;365:l794
pubmed: 30962184
J Affect Disord. 2018 Jan 1;225:503-522
pubmed: 28866295
Psychother Psychosom. 2015;84(3):167-76
pubmed: 25831962
BMC Psychiatry. 2020 Sep 10;20(1):446
pubmed: 32912183
J Psychosom Res. 2017 Oct;101:44-50
pubmed: 28867423
JAMA. 1999 Nov 10;282(18):1737-44
pubmed: 10568646
Int J Methods Psychiatr Res. 2003;12(2):85-91
pubmed: 12830302
PLoS One. 2016 Jun 16;11(6):e0156939
pubmed: 27310297
J Psychosom Res. 2017 Dec;103:42-62
pubmed: 29167047
Am J Obstet Gynecol. 2000 Sep;183(3):759-69
pubmed: 10992206
Psychiatry Res. 2013 Dec 15;210(2):653-61
pubmed: 23972787
BMC Psychiatry. 2014 Jul 07;14:194
pubmed: 24999041
Soc Sci Med. 2020 Feb;246:112760
pubmed: 32006814
BMC Med. 2017 Aug 9;15(1):150
pubmed: 28789659
PLoS Med. 2013 Nov;10(11):e1001547
pubmed: 24223526
Int J Ment Health Addict. 2022;20(3):1824-1833
pubmed: 33495691
J Affect Disord. 2009 Feb;113(1-2):109-17
pubmed: 18614241
Prev Sci. 2011 Dec;12(4):361-71
pubmed: 21732121
Br J Psychiatry. 2016 Jan;208 Suppl 56:s4-12
pubmed: 26447174
Malawi Med J. 2014 Jun;26(2):34-7
pubmed: 25157314
Bull World Health Organ. 2010 Nov 1;88(11):815-23
pubmed: 21076562
PLoS One. 2017 Aug 3;12(8):e0182162
pubmed: 28771530
Lancet. 2009 Aug 22;374(9690):609-19
pubmed: 19640579
Psychol Med. 1985 Feb;15(1):189-94
pubmed: 3991833
PLoS Med. 2006 Nov;3(11):e442
pubmed: 17132052
J Affect Disord. 2020 Jan 15;261:21-29
pubmed: 31600584
Lancet Psychiatry. 2016 Feb;3(2):171-8
pubmed: 26851330
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
Med Care. 2003 Nov;41(11):1284-92
pubmed: 14583691
Cureus. 2020 May 21;12(5):e8224
pubmed: 32582485
Arch Intern Med. 2000 Jul 10;160(13):1913-21
pubmed: 10888966
J Affect Disord. 2015 Nov 1;186:32-9
pubmed: 26226431
Health Qual Life Outcomes. 2017 Apr 5;15(1):64
pubmed: 28381230
BMC Psychiatry. 2013 Mar 13;13:83
pubmed: 23497463

Auteurs

Kassahun Habtamu (K)

School of Psychology, College of Education and Behavioral Studies, Addis Ababa University, P.O.BOX: 1176, Addis Ababa, Ethiopia. Kasshabmek@gmail.com.

Rahel Birhane (R)

Department of Psychiatry, School of Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.

Girmay Medhin (G)

Aklilu Lemma Institute of Pathobiology, Addis Ababa University, Addis Ababa, Ethiopia.

Charlotte Hanlon (C)

Department of Psychiatry, School of Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Centre for Global Mental Health, Health Service and Population Research Department, and WHO Collaborating Centre for Mental Health Research and Training, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

Abebaw Fekadu (A)

Department of Psychiatry, School of Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Centre for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), Addis Ababa University, Addis Ababa, Ethiopia.
Global Health & Infection Department, Brighton and Sussex Medical School, Brighton, UK.
Center for Affective Disorders, Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH